[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Human Insulin Market Report 2017

October 2017 | 100 pages | ID: A749BD3939BEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Human Insulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (Kg), revenue (Million USD), market share and growth rate of Human Insulin for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Human Insulin market competition by top manufacturers/players, with Human Insulin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Sanofi (France)
  • Eli Lilly and Company (U.S.)
  • Biocon Ltd. (India)
  • Julphar (U.A.E.)
  • Ypsomed AG (Switzerland)
  • Becton
  • Dickinson and Company (U.S.)
  • Wockhardt Ltd. (India)
  • B. Braun Meselgen AG (Switzerland)
  • Biodel Inc(U.S.)
On the basis of product, this report displays the sales volume (Kg), revenue (Million USD), product price (USD/g), market share and growth rate of each type, primarily split into
  • Short Acting Human Insulin
  • Intermediate Acting Human Insulin
  • Premixed Human Insulin
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (Kg), market share and growth rate of Human Insulin for each application, includin
  • Insulin Dependent Diabetes Mellitus
  • Non-Insulin Dependent Diabetes Mellitus
Asia-Pacific Human Insulin Market Report 2017

1 HUMAN INSULIN OVERVIEW

1.1 Product Overview and Scope of Human Insulin
1.2 Classification of Human Insulin by Product Category
  1.2.1 Asia-Pacific Human Insulin Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Human Insulin Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Short Acting Human Insulin
  1.2.4 Intermediate Acting Human Insulin
  1.2.5 Premixed Human Insulin
1.3 Asia-Pacific Human Insulin Market by Application/End Users
  1.3.1 Asia-Pacific Human Insulin Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Insulin Dependent Diabetes Mellitus
  1.3.3 Non-Insulin Dependent Diabetes Mellitus
1.4 Asia-Pacific Human Insulin Market by Region
  1.4.1 Asia-Pacific Human Insulin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Human Insulin (2012-2022)
  1.5.1 Asia-Pacific Human Insulin Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Human Insulin Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC HUMAN INSULIN COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Human Insulin Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Human Insulin Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Human Insulin Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Human Insulin (Volume and Value) by Type
  2.2.1 Asia-Pacific Human Insulin Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Human Insulin Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Human Insulin (Volume) by Application
2.4 Asia-Pacific Human Insulin (Volume and Value) by Region
  2.4.1 Asia-Pacific Human Insulin Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Human Insulin Revenue and Market Share by Region (2012-2017)

3 CHINA HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

3.1 China Human Insulin Sales and Value (2012-2017)
  3.1.1 China Human Insulin Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Human Insulin Revenue and Growth Rate (2012-2017)
  3.1.3 China Human Insulin Sales Price Trend (2012-2017)
3.2 China Human Insulin Sales Volume and Market Share by Type
3.3 China Human Insulin Sales Volume and Market Share by Application

4 JAPAN HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Human Insulin Sales and Value (2012-2017)
  4.1.1 Japan Human Insulin Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Human Insulin Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Human Insulin Sales Price Trend (2012-2017)
4.2 Japan Human Insulin Sales Volume and Market Share by Type
4.3 Japan Human Insulin Sales Volume and Market Share by Application

5 SOUTH KOREA HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Human Insulin Sales and Value (2012-2017)
  5.1.1 South Korea Human Insulin Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Human Insulin Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Human Insulin Sales Price Trend (2012-2017)
5.2 South Korea Human Insulin Sales Volume and Market Share by Type
5.3 South Korea Human Insulin Sales Volume and Market Share by Application

6 TAIWAN HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Human Insulin Sales and Value (2012-2017)
  6.1.1 Taiwan Human Insulin Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Human Insulin Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Human Insulin Sales Price Trend (2012-2017)
6.2 Taiwan Human Insulin Sales Volume and Market Share by Type
6.3 Taiwan Human Insulin Sales Volume and Market Share by Application

7 INDIA HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

7.1 India Human Insulin Sales and Value (2012-2017)
  7.1.1 India Human Insulin Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Human Insulin Revenue and Growth Rate (2012-2017)
  7.1.3 India Human Insulin Sales Price Trend (2012-2017)
7.2 India Human Insulin Sales Volume and Market Share by Type
7.3 India Human Insulin Sales Volume and Market Share by Application

8 SOUTHEAST ASIA HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Human Insulin Sales and Value (2012-2017)
  8.1.1 Southeast Asia Human Insulin Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Human Insulin Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Human Insulin Sales Price Trend (2012-2017)
8.2 Southeast Asia Human Insulin Sales Volume and Market Share by Type
8.3 Southeast Asia Human Insulin Sales Volume and Market Share by Application

9 AUSTRALIA HUMAN INSULIN (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Human Insulin Sales and Value (2012-2017)
  9.1.1 Australia Human Insulin Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Human Insulin Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Human Insulin Sales Price Trend (2012-2017)
9.2 Australia Human Insulin Sales Volume and Market Share by Type
9.3 Australia Human Insulin Sales Volume and Market Share by Application

10 ASIA-PACIFIC HUMAN INSULIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Sanofi (France)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Human Insulin Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Sanofi (France) Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Eli Lilly and Company (U.S.)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Human Insulin Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Eli Lilly and Company (U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Biocon Ltd. (India)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Human Insulin Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Biocon Ltd. (India) Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Julphar (U.A.E.)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Human Insulin Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Julphar (U.A.E.) Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Ypsomed AG (Switzerland)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Human Insulin Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Ypsomed AG (Switzerland) Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Becton
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Human Insulin Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Becton Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Dickinson and Company (U.S.)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Human Insulin Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Dickinson and Company (U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Wockhardt Ltd. (India)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Human Insulin Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Wockhardt Ltd. (India) Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 B. Braun Meselgen AG (Switzerland)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Human Insulin Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 B. Braun Meselgen AG (Switzerland) Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Biodel Inc(U.S.)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Human Insulin Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Biodel Inc(U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 HUMAN INSULIN MANUFACTURING COST ANALYSIS

11.1 Human Insulin Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Human Insulin

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Human Insulin Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Human Insulin Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC HUMAN INSULIN MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Human Insulin Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Human Insulin Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Human Insulin Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Human Insulin Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Human Insulin Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Human Insulin Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Human Insulin Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Human Insulin Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Human Insulin Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Human Insulin Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Human Insulin Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Human Insulin Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Human Insulin Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Human Insulin
Figure Asia-Pacific Human Insulin Sales Volume (Kg) by Type (2012-2022)
Figure Asia-Pacific Human Insulin Sales Volume Market Share by Type (Product Category) in 2016
Figure Short Acting Human Insulin Product Picture
Figure Intermediate Acting Human Insulin Product Picture
Figure Premixed Human Insulin Product Picture
Figure Asia-Pacific Human Insulin Sales (Kg) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Human Insulin by Application in 2016
Figure Insulin Dependent Diabetes Mellitus Examples
Figure Non-Insulin Dependent Diabetes Mellitus Examples
Figure Asia-Pacific Human Insulin Market Size (Million USD) by Region (2012-2022)
Figure China Human Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Human Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Human Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Human Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Human Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Human Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Human Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Human Insulin Sales Volume (Kg) and Growth Rate (2012-2022)
Figure Asia-Pacific Human Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Human Insulin Market Major Players Product Sales Volume (Kg)(2012-2017)
Table Asia-Pacific Human Insulin Sales (Kg) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Human Insulin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Human Insulin Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Human Insulin Sales Share by Players/Suppliers
Figure Asia-Pacific Human Insulin Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Human Insulin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Human Insulin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Human Insulin Revenue Share by Players
Figure 2017 Asia-Pacific Human Insulin Revenue Share by Players
Table Asia-Pacific Human Insulin Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Human Insulin Sales Share by Type (2012-2017)
Figure Sales Market Share of Human Insulin by Type (2012-2017)
Figure Asia-Pacific Human Insulin Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Human Insulin Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Human Insulin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Insulin by Type (2012-2017)
Figure Asia-Pacific Human Insulin Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Human Insulin Sales Volume (Kg) and Market Share by Region (2012-2017)
Table Asia-Pacific Human Insulin Sales Share by Region (2012-2017)
Figure Sales Market Share of Human Insulin by Region (2012-2017)
Figure Asia-Pacific Human Insulin Sales Market Share by Region in 2016
Table Asia-Pacific Human Insulin Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Human Insulin Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Human Insulin by Region (2012-2017)
Figure Asia-Pacific Human Insulin Revenue Market Share by Region in 2016
Table Asia-Pacific Human Insulin Sales Volume (Kg) and Market Share by Application (2012-2017)
Table Asia-Pacific Human Insulin Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Human Insulin Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Human Insulin Sales Market Share by Application (2012-2017)
Figure China Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure China Human Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Human Insulin Sales Price (USD/g) Trend (2012-2017)
Table China Human Insulin Sales Volume (Kg) by Type (2012-2017)
Table China Human Insulin Sales Volume Market Share by Type (2012-2017)
Figure China Human Insulin Sales Volume Market Share by Type in 2016
Table China Human Insulin Sales Volume (Kg) by Applications (2012-2017)
Table China Human Insulin Sales Volume Market Share by Application (2012-2017)
Figure China Human Insulin Sales Volume Market Share by Application in 2016
Figure Japan Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Japan Human Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Human Insulin Sales Price (USD/g) Trend (2012-2017)
Table Japan Human Insulin Sales Volume (Kg) by Type (2012-2017)
Table Japan Human Insulin Sales Volume Market Share by Type (2012-2017)
Figure Japan Human Insulin Sales Volume Market Share by Type in 2016
Table Japan Human Insulin Sales Volume (Kg) by Applications (2012-2017)
Table Japan Human Insulin Sales Volume Market Share by Application (2012-2017)
Figure Japan Human Insulin Sales Volume Market Share by Application in 2016
Figure South Korea Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure South Korea Human Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Human Insulin Sales Price (USD/g) Trend (2012-2017)
Table South Korea Human Insulin Sales Volume (Kg) by Type (2012-2017)
Table South Korea Human Insulin Sales Volume Market Share by Type (2012-2017)
Figure South Korea Human Insulin Sales Volume Market Share by Type in 2016
Table South Korea Human Insulin Sales Volume (Kg) by Applications (2012-2017)
Table South Korea Human Insulin Sales Volume Market Share by Application (2012-2017)
Figure South Korea Human Insulin Sales Volume Market Share by Application in 2016
Figure Taiwan Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Taiwan Human Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Human Insulin Sales Price (USD/g) Trend (2012-2017)
Table Taiwan Human Insulin Sales Volume (Kg) by Type (2012-2017)
Table Taiwan Human Insulin Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Human Insulin Sales Volume Market Share by Type in 2016
Table Taiwan Human Insulin Sales Volume (Kg) by Applications (2012-2017)
Table Taiwan Human Insulin Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Human Insulin Sales Volume Market Share by Application in 2016
Figure India Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure India Human Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Human Insulin Sales Price (USD/g) Trend (2012-2017)
Table India Human Insulin Sales Volume (Kg) by Type (2012-2017)
Table India Human Insulin Sales Volume Market Share by Type (2012-2017)
Figure India Human Insulin Sales Volume Market Share by Type in 2016
Table India Human Insulin Sales Volume (Kg) by Application (2012-2017)
Table India Human Insulin Sales Volume Market Share by Application (2012-2017)
Figure India Human Insulin Sales Volume Market Share by Application in 2016
Figure Southeast Asia Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Southeast Asia Human Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Human Insulin Sales Price (USD/g) Trend (2012-2017)
Table Southeast Asia Human Insulin Sales Volume (Kg) by Type (2012-2017)
Table Southeast Asia Human Insulin Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Human Insulin Sales Volume Market Share by Type in 2016
Table Southeast Asia Human Insulin Sales Volume (Kg) by Applications (2012-2017)
Table Southeast Asia Human Insulin Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Human Insulin Sales Volume Market Share by Application in 2016
Figure Australia Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Australia Human Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Human Insulin Sales Price (USD/g) Trend (2012-2017)
Table Australia Human Insulin Sales Volume (Kg) by Type (2012-2017)
Table Australia Human Insulin Sales Volume Market Share by Type (2012-2017)
Figure Australia Human Insulin Sales Volume Market Share by Type in 2016
Table Australia Human Insulin Sales Volume (Kg) by Applications (2012-2017)
Table Australia Human Insulin Sales Volume Market Share by Application (2012-2017)
Figure Australia Human Insulin Sales Volume Market Share by Application in 2016
Table Sanofi (France) Human Insulin Basic Information List
Table Sanofi (France) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure Sanofi (France) Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Sanofi (France) Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi (France) Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lilly and Company (U.S.) Human Insulin Basic Information List
Table Eli Lilly and Company (U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure Eli Lilly and Company (U.S.) Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Eli Lilly and Company (U.S.) Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly and Company (U.S.) Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table Biocon Ltd. (India) Human Insulin Basic Information List
Table Biocon Ltd. (India) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure Biocon Ltd. (India) Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Biocon Ltd. (India) Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure Biocon Ltd. (India) Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table Julphar (U.A.E.) Human Insulin Basic Information List
Table Julphar (U.A.E.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure Julphar (U.A.E.) Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Julphar (U.A.E.) Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure Julphar (U.A.E.) Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table Ypsomed AG (Switzerland) Human Insulin Basic Information List
Table Ypsomed AG (Switzerland) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure Ypsomed AG (Switzerland) Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Ypsomed AG (Switzerland) Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure Ypsomed AG (Switzerland) Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table Becton Human Insulin Basic Information List
Table Becton Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure Becton Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Becton Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure Becton Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table Dickinson and Company (U.S.) Human Insulin Basic Information List
Table Dickinson and Company (U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure Dickinson and Company (U.S.) Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Dickinson and Company (U.S.) Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure Dickinson and Company (U.S.) Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table Wockhardt Ltd. (India) Human Insulin Basic Information List
Table Wockhardt Ltd. (India) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure Wockhardt Ltd. (India) Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Wockhardt Ltd. (India) Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure Wockhardt Ltd. (India) Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table B. Braun Meselgen AG (Switzerland) Human Insulin Basic Information List
Table B. Braun Meselgen AG (Switzerland) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table Biodel Inc(U.S.) Human Insulin Basic Information List
Table Biodel Inc(U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2012-2017)
Figure Biodel Inc(U.S.) Human Insulin Sales (Kg) and Growth Rate (2012-2017)
Figure Biodel Inc(U.S.) Human Insulin Sales Market Share in Asia-Pacific (2012-2017)
Figure Biodel Inc(U.S.) Human Insulin Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/g) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Insulin
Figure Manufacturing Process Analysis of Human Insulin
Figure Human Insulin Industrial Chain Analysis
Table Raw Materials Sources of Human Insulin Major Manufacturers in 2016
Table Major Buyers of Human Insulin
Table Distributors/Traders List
Figure Asia-Pacific Human Insulin Sales Volume (Kg) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Human Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Human Insulin Price (USD/g) and Trend Forecast (2017-2022)
Table Asia-Pacific Human Insulin Sales Volume (Kg) Forecast by Region (2017-2022)
Figure Asia-Pacific Human Insulin Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Human Insulin Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Human Insulin Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Human Insulin Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Human Insulin Revenue Market Share Forecast by Region in 2022
Figure China Human Insulin Sales (Kg) and Growth Rate Forecast (2017-2022)
Figure China Human Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Human Insulin Sales (Kg) and Growth Rate Forecast (2017-2022)
Figure Japan Human Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Human Insulin Sales (Kg) and Growth Rate Forecast (2017-2022)
Figure South Korea Human Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Human Insulin Sales (Kg) and Growth Rate Forecast (2017-2022)
Figure Taiwan Human Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Human Insulin Sales (Kg) and Growth Rate Forecast (2017-2022)
Figure India Human Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Human Insulin Sales (Kg) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Human Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Human Insulin Sales (Kg) and Growth Rate Forecast (2017-2022)
Figure Australia Human Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Human Insulin Sales (Kg) Forecast by Type (2017-2022)
Figure Asia-Pacific Human Insulin Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Human Insulin Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Human Insulin Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Human Insulin Price (USD/g) Forecast by Type (2017-2022)
Table Asia-Pacific Human Insulin Sales (Kg) Forecast by Application (2017-2022)
Figure Asia-Pacific Human Insulin Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories